Poster presentation to demonstrate EBT-107’s potential to reduce clinically-relevant biomarkers and HBV DNA integration toward functional remission of chronic hepatitis B ; Oral ...

LONDON and NEW YORK, May 13, 2025 (GLOBE NEWSWIRE) -- MeiraGTx Holdings plc (Nasdaq: MGTX), a vertically integrated, clinical-stage genetic medicines company, today announced financial and operational ...

The French biotechnology firm aims to develop therapies for various neurological conditions using its non-replicating HSV-1 vector technology.

NewBiologix, a next-generation biotechnology company pioneering the future of recombinant adeno-associated virus (rAAV) production through a unique DNA-based platform built on stable cell line ...

Tozaro, an emerging technology provider in the field of cell and gene therapy manufacturing, announces the formation of its ...

Data highlights advantages of single, non-replicative HSV-1 (nrHSV-1) vector hosting two transgenes with independent ...

Tencent Cloud and Vector Group's Offshore Company Launch Japan's First AI Avatar Video Generation Service "AvaMo” ...

A Forrester VP explains to TechRepublic readers why three of the top 10 emerging technologies for the year should be on ...

Colossal Biosciences, a Texas-based biotech company, made headlines this April after falsely claiming to resurrect the ...

Andelyn Biosciences Inc. successfully manufactured a novel viral vector gene therapy to treat a baby with the ultra-rare ...

Slopsquatting is the most recent form of dependency chain attack. The new attack vector should be a wake-up call for ...

If there are few speakers left of a language, how does a community revive it? In our current era, 3,000 languages are at risk ...